Cyclin D3 Antibody MA5-12717 from Thermo Fisher Scientific

Product Specs
ItemCyclin D3 Antibody
CompanyThermo Fisher Scientific
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberMA5-12717
HostMouse
FormatPBS with 0.2% BSA and 0.09% sodium azide; pH 7.4
IsotypeIgG1 kappa
Brand/TrademarkABR (now Thermo Scientific Pierce Antibodies)
Conjugate/TagUnconjugated
CloneDCS-22
TargetCyclin D3
ReactivityHuman, Mouse, Non-human primate, Rat
Quantity500 µL
ApplicationsImmunohistochemistry (Paraffin), Immunoprecipitation, Western Blot
ClonalityMonoclonal
NCBI Full Gene Namecyclin D3
Concentration0.2 mg/mL
ImmunogenPurified human recombinant full length cyclin D3 protein
NCBI Gene Aliases9230106B05Rik
Storage Temperature4° C
PurityProtein G
Antibody TypePrimary
Storage4° C

Add to Compare List

Thermo Fisher Scientific

81 Wyman Street

Waltham, MA 02451

United States

Phone: 800-678-5599
Fax: 800-331-2286

Company Profile

Website: www.thermofisher.com

(1) CRL4^AMBRA1 is a master regulator of D-type cyclinsNatureApril 1, 2021Simoneschi D, Rona G, Zhou N, Jeong YT, Jiang S, Milletti G, Arbini AA, O'Sullivan A, Wang AA, Nithikasem S, et al.cyclin D2 (1:1,000, Cell Signaling Technology 3741S), cyclin D3 (1:1,000, Thermo Fisher Scientific MA5–12717), p-cyclin D3 (T283) (1:1,000, Cell Signaling Technology 53966S), cyclin E (1:1,000, Santa Cruz Biotechnology

(2) A Proteomic Survey Indicates Sortilin as a Secondary Substrate of the ER Translocation Inhibitor Cyclotriazadisulfonamide (CADA)Molecular & cellular proteomics : MCPFebruary 1, 2017Van Puyenbroeck V, Claeys E, Schols D, Bell TW, Vermeire K.

(3) Inhibition of mutant BRAF splice variant signaling by next-generation, selective RAF inhibitorsPigment cell & melanoma researchMay 1, 2014Basile KJ, Le K, Hartsough EJ, Aplin AE.

(4) The CDK4/CDK6 inhibitor PD0332991 paradoxically stabilizes activated cyclin D3-CDK4/6 complexesCell cycle (Georgetown, Tex.)January 1, 2014Paternot S, Colleoni B, Bisteau X, Roger PP.

(5) CDK4 T172 phosphorylation is central in a CDK7-dependent bidirectional CDK4/CDK2 interplay mediated by p21 phosphorylation at the restriction pointPLoS geneticsMay 1, 2013Bisteau X, Paternot S, Colleoni B, Ecker K, Coulonval K, De Groote P, Declercq W, Hengst L, Roger PP.

(6) Alteration of G1/S transition regulators influences recurrences in head and neck squamous carcinomasJournal of cellular physiologyJanuary 1, 2012Canzonieri V, Barzan L, Franchin G, Vaccher E, Talamini R, Sulfaro S, Baldassarre G.

(7) Death effector domain-containing protein (DEDD) is required for uterine decidualization during early pregnancy in miceThe Journal of clinical investigationJanuary 1, 2011Mayumi Mori, Miwako Kitazume, Rui Ose, Jun Kurokawa, Kaori Koga, Yutaka Osuga, Satoko Arai, Toru Miyazaki

(8) β-catenin/cyclin D1 mediated development of suture mesenchyme in calvarial morphogenesisBMC developmental biologyNovember 26, 2010Mirando AJ, Maruyama T, Fu J, Yu HM, Hsu W.

(9) cAMP-dependent activation of mammalian target of rapamycin (mTOR) in thyroid cells. Implication in mitogenesis and activation of CDK4Molecular endocrinology (Baltimore, Md.)July 1, 2010Sara Blancquaert, Lifu Wang, Sabine Paternot, Katia Coulonval, Jacques E Dumont, Thurl E Harris, Pierre P Roger

(10) Expression of cyclin D2 is an independent predictor of the development of hepatic metastasis in colorectal cancerColorectal disease : the official journal of the Association of Coloproctology of Great Britain and IrelandApril 1, 2010Sarkar R, Hunter IA, Rajaganeshan R, Perry SL, Guillou P, Jayne DG.

(11) Differential regulation of cyclin-dependent kinase 4 (CDK4) and CDK6, evidence that CDK4 might not be activated by CDK7, and design of a CDK6 activating mutationMolecular and cellular biologyAugust 1, 2009Bockstaele L, Bisteau X, Paternot S, Roger PP.

(12) Identification of a potent natural triterpenoid inhibitor of proteosome chymotrypsin-like activity and NF-kappaB with antimyeloma activity in vitro and in vivoBloodApril 23, 2009Tiedemann RE, Schmidt J, Keats JJ, Shi CX, Zhu YX, Palmer SE, Mao X, Schimmer AD, Stewart AK.

(13) Orphan receptor small heterodimer partner suppresses tumorigenesis by modulating cyclin D1 expression and cellular proliferationHepatology (Baltimore, Md.)July 1, 2008Zhang Y, Xu P, Park K, Choi Y, Moore DD, Wang L.

(14) Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic ProgramJournal of clinical oncology : official journal of the American Society of Clinical OncologyJuly 1, 2007Filipits M, Pirker R, Dunant A, Lantuejoul S, Schmid K, Huynh A, Haddad V, André F, Stahel R, Pignon JP, et al.

(15) Nuclear localization of barrier-to-autointegration factor is correlated with progression of S phase in human cellsJournal of cell scienceJune 15, 2007Haraguchi T, Koujin T, Osakada H, Kojidani T, Mori C, Masuda H, Hiraoka Y.

(16) Differential utilization of cyclin D1 and cyclin D3 in the distinct mitogenic stimulations by growth factors and TSH of human thyrocytes in primary cultureMolecular endocrinology (Baltimore, Md.)December 1, 2006Paternot S, Dumont JE, Roger PP.

(17) "Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK ""inhibitors"""Molecular and cellular biologyJuly 1, 2006Bockstaele L, Kooken H, Libert F, Paternot S, Dumont JE, de Launoit Y, Roger PP, Coulonval K.

(18) Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3Cancer researchMarch 1, 2006Leslie K, Lang C, Devgan G, Azare J, Berishaj M, Gerald W, Kim YB, Paz K, Darnell JE, Albanese C, et al.

(19) Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomasBloodJanuary 15, 2006Piva R, Chiarle R, Manazza AD, Taulli R, Simmons W, Ambrogio C, D'Escamard V, Pellegrino E, Ponzetto C, Palestro G, et al.

(20) Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profilingBloodDecember 15, 2005Fu K, Weisenburger DD, Greiner TC, Dave S, Wright G, Rosenwald A, Chiorazzi M, Iqbal J, Gesk S, Siebert R, et al.

Be the First to Write a Review!

IHC

Cyclin D3 Antibody

Cyclin D3 Antibody from Thermo Fisher Scientific

Thermo Fisher Scientific

Citations (33)

Reviews

Cyclin D3 Antibody from Thermo Fisher Scientific

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map